3 Patents
- US123382872025Treatment of Cancer Using a CD33 Chimeric Antigen Receptor
The Trustees Of The University Of Pennsylvania
0 cites - US122140372025Treatment of Cancer Using Humanized Anti-bcma Chimeric Antigen Receptor
The Trustees Of The University Of Pennsylvania
0 cites - US121862782025Mesothelin Chimeric Antigen Receptor (CAR) and Antibody Against PD-L1 Inhibitor for Combined Use in Anticancer Therapy
President And Fellows Of Harvard College
0 cites